نظرة عامة على البرنامج

---

Introduction to the IMPACCT Rapid Paediatric Program

The IMPACCT Rapid Paediatric Program aims to gather large amounts of data in a short space of time to improve care of children in palliative care or who are experiencing chronic pain.

Paediatrics

Physiotherapy for Respiratory Deterioration - series 54

Respiratory distress is one of the leading causes to parents presenting with their child to emergency departments, with symptoms being common, recurrent, and distressing. Contemporary research has identified deterioration in respiratory status as being associated with significantly increased morbidity, impacting quality of life, reduced participation and life expectancy.

• Physiotherapy is a common first-line strategy requested to relieve increased work of breathing.
• Physiotherapists experience working with paediatric patients with multiple co-morbidities, including complex neurodisabilities.
• Choice of management strategy and response to deteriorations need to be individualised to each patient and condition.

Paediatric medicinal cannabinoids in palliative care - series 43

We want to understand what symptoms medicinal cannabis is being prescribed for in paediatric palliative care.

• Medicinal cannabis may be useful for managing treatment-resistant epilepsy, pain and other symptoms that can affect many children in palliative care.
• Medicinal cannabis may have an adjuvant or complementary role in symptom management but supporting evidence for its use and the most suitable doses is limited.

Paediatric chronic pain

Ketamine for non-cancer pain - series 41

In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain in real-life situations.

• The series is designed to minimise the workload for any individual site through multi-site collaboration and enable Rapid data collection relatively quickly and easily.
• In this study, the data points are at baseline then 48 hours, 72 hours, and 96 hours after baseline, and then three months after the ketamine infusion has ceased.

Ketamine for cancer-related mucositis pain - series 42

In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.

• The series is designed to minimise the workload for any individual site through multi-site collaboration and enable Rapid data collection relatively quickly and easily.
• In this study, the data points are at baseline then 48 hours, 5 days and 10 days after baseline.

University Overview

The University of Technology Sydney acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people upon whose ancestral lands our university stands.

Study Options

• Find a course
• Undergraduate
• Postgraduate
• How to apply
• Scholarships and prizes
• International students
• Campus maps
• Accommodation

Engagement

• Find an expert
• Industry
• News
• Events
• Experience UTS
• Research
• Stories
• Alumni

About the University

• Who we are
• Faculties
• Learning and teaching
• Sustainability
• Initiatives
• Equity, diversity and inclusion
• Campus and locations
• Awards and rankings
• Leadership and governance

Staff and Students

• Current students
• Help and support
• Library
• Policies
• StaffConnect
• Working at UTS
• UTS Handbook
• Contact information removed for privacy

University Details

• Copyright
• ABN:
• CRICOS provider number: 00099F
• TEQSA provider number: PRV12060
• TEQSA category: Australian University

Policies

• Privacy
• Copyright
• Disclaimer
• Accessibility